A Study to Evaluate the Pharmacokinetics of Rilpivirine/Tenofovir/Emtricitabine After a Single-Oral Administration in Healthy Japanese Adult Male Participants
Clinical trial NCT02530060 · COMPLETED
Trial details
- NCT number
- NCT02530060
- Sponsor
- Janssen Pharmaceutical K.K.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2015-09-01
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.